Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Plos One|April 6, 2011
Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in UgandaJoseph B Babigumira, Barbara Castelnuovo, Andy Stergachis, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impactsMaarten J Postma, George Milne, E Anthony S Nelson, et al.
BMJ Open|May 4, 2023
Assessing the potential cost-effectiveness of centralised versus point-of-care testing for hepatitis C virus in Pakistan: a model-based comparisonJoseph B Babigumira, James K Karichu, Samantha Clark, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2017
Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in KenyaMarita R Zimmermann, Elisabeth Vodicka, Joseph B Babigumira, et al.
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Using Certification to Promote Uptake of Real-World Evidence by PayersJodi B Segal, Joel D Kallich, Emma R Oppenheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approachVincent W Lin, Edwin S Wong, Andrew Wright, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2016
Sentinel site active surveillance of safety of first-line antiretroviral medicines in NamibiaMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.
International Journal of Technology Assessment in Health Care|December 12, 2024
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessmentSiobhan Bourke, Chris Skedgel, Yasmina Martí-Gil, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.
Pageof 19